Aim: The aim of this study was to find the relationship between rs1799964 in TNF-a gene as well as rs1051208 of RAF1 gene SNPs on GC in an Iranian population.
Background: Gastric cancer (GC) is the second leading cause of cancer-related death worldwide after lung cancer. Tumor necrosis factor (TNF) is one of the most important factors in the pathogenesis of this cancer. Single nucleotide polymorphisms have a principle role in gene expression of TNF-a and miRNAs which may lead to gastric cancer.
Methods: In a case-control study, we investigated the risk of GC in 198 Iranians. For this purpose, 5 mL of peripheral blood was collected in EDTA –containing tube and genomic DNA was isolated. Genotyping of SNPs was also performed by PCR-RFLP; to approve the outcome, 10% of genotyping results with RFLP were sequenced.
Results: The comparison between case and control groups revealed a significant association between the rs1051208 C allele of RAF1 gene and GC (P = 0.04). We did not observe any remarkable association between TNF-a -1031 in gastric cancer patients and the healthy control group.
Conclusion: The results indicated that C allele in RAF1 gene plays a role in susceptibility to gastric cancer. Therefore, SNPs are among notable biomarkers for predicting susceptibility to dreadful diseases, especially cancers.
Keywords: single nucleoid polymorphism, Gastric cancer, Tumor necrosis factor, microRNA
Lee, S.-G., B. Kim, J.-H. Yook, S.-T. Oh, I. Lee, and K. Song, TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine, 2004. 28(2): p. 75-82.
Talebi Bezmin Abadi, A., A. Rafiei, A. Ajami, V. Hosseini, T. Taghvaei, K.R. Jones, and D.S. Merrell, Helicobacter pylori homB, but Not cagA, Is Associated with Gastric Cancer in Iran. Journal of Clinical Microbiology, 2011. 49(9): p. 3191-3197.
Lu, R., X. Dou, X. Gao, J. Zhang, J. Ni, and L. Guo, A functional polymorphism of lymphotoxin-alpha (LTA) gene rs909253 is associated with gastric cancer risk in an Asian population. Cancer Epidemiology, 2012.
Malekzadeh, R., M.H. Derakhshan, and Z. Malekzadeh, Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 2009. 12(6): p. 576-83.
Perez-Perez, G.I., E. Garza-Gonzalez, C. Portal, and A.Z. Olivares, Role of cytokine polymorphisms in the risk of distal gastric cancer development. Cancer Epidemiology Biomarkers & Prevention, 2005. 14(8): p. 1869-1873.
Radmard, A.R., Five common cancers in Iran. Archives of Iranian medicine, 2010. 13(2): p. 143-146.
Babaei, M., F. Pourfarzi, A. Yazdanbod, M.M. Chiniforush, M.H. Derakhshan, S.M. Mousavi, F. Samadi, and G. Rahimi, Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. Asian Pac J Cancer Prev, 2010. 11(3): p. 595-9.
Fritz, E.L., Helicobacter pylori and gastric cancer. Continuing Medical Education, 2009. 27(5).
Tsuji, S., M. Tsujii, H. Murata, T. Nishida, M. Komori, M. Yasumaru, S. Ishii, Y. Sasayama, S. Kawano, and N. Hayashi, Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms. World Journal of Gastroenterology, 2006. 12(11): p. 1671.
Hishida, A., Genetic Factors Involved in the Genesis of Helicobacter Pylori-Induced Gastric Cancer.
Yin, Y.-W., A.-M. Hu, Q.-Q. Sun, B.-B. Zhang, Q. Wang, H.-L. Liu, Y.-H. Zeng, R.-J. Xu, S.-J. Zhang, and L.-B. Shi, Association between interleukin-8 gene-251 T/A polymorphism and the risk of peptic ulcer disease: A meta-analysis. Human Immunology, 2012.
Toosi, M., H. Rafatpanah, J. Afshar, M. Nassiri, H. Sima, M. Moghani, and R. Ganjali, The role of tumor necrosis factor-α promoter polymorphisms in gastric carcinoma in Iranians: a case-control study in the North-East of Iran. Govaresh, 2007. 12(3): p. 192-199.
Gorouhi, F., F. Islami, H. Bahrami, and F. Kamangar, Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. British Journal of Cancer, 2008. 98(8): p. 1443-1451.
Xue, H., B. Lin, J. An, Y. Zhu, and G. Huang, Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC cancer, 2012. 12(1): p. 102.
Fan, X., A. Chua, X. Fan, and P. Keeling, Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. Journal of Clinical Pathology, 1995. 48(2): p. 133-136.
Fei, B.-Y., B. Xia, C.-S. Deng, X.-Q. Xia, M. Xie, J.B.A. Crusius, and A.S. Pena, Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population. 2004.
Forones, N., S. Mandowsky, and L. Lourenco, Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Hepato-Gastroenterology, 2001. 48(40): p. 1199.
Fiorucci, S., L. Santucci, G. Migliorati, C. Riccardi, A. Amorosi, A. Mancini, R. Roberti, and A. Morelli, Isolated guinea pig gastric chief cells express tumour necrosis factor receptors coupled with the sphingomyelin pathway. Gut, 1996. 38(2): p. 182-189.
Peek, R.M. and M.J. Blaser, Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Reviews Cancer, 2002. 2(1): p. 28-37.
Yang, J.J., K.-P. Ko, L.Y. Cho, A. Shin, J. Gwack, S.-H. Chang, H.-R. Shin, K.-Y. Yoo, D. Kang, and S.K. Park, The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC cancer, 2009. 9(1): p. 238.
Abdiev, S., K.S. Ahn, A. Khadjibaev, Y. Malikov, S. Bahramov, B. Rakhimov, J. Sakamoto, Y. Kodera, A. Nakano, and N. Hamajima, Helicobacter Pylori Infection and Cytokines Gene Polymorphisms in Uzbeks. Nagoya Journal of Medical Science, 2010. 72(3-4): p. 167-172.
Felekkis, K., E. Touvana, C. Stefanou, and C. Deltas, microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia, 2010. 14(4): p. 236.
Chen, K., F. Song, G.A. Calin, Q. Wei, X. Hao, and W. Zhang, Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis, 2008. 29(7): p. 1306-1311.
Landi, D., F. Gemignani, R. Barale, and S. Landi, A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA and Cell Biology, 2008. 27(1): p. 35-43.
Schetter, A.J., H. Okayama, and C.C. Harris, The role of microRNAs in colorectal cancer. Cancer J, 2012. 18(3): p. 244-52.
Azimzadeh, P., S. Romani, S.R. Mohebbi, T. Mahmoudi, M. Vahedi, S.R. Fatemi, N. Zali, and M.R. Zali, Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population. Cancer Genetics, 2012. 205(10): p. 501-507.
Suguna, S., D. Nandal, S. Kamble, A. Bharatha, and R. Kunkulol, Genomic DNA isolation from human whole blood samples by non enzymatic salting out method. Int J Pharm Pharm Sci, 2014. 6: p. 198-199.
Yao, B., Y. Zhang, S. Delikat, S. Mathias, S. Basu, and R. Kolesnick, Phosphorylation of Raf by ceramide-activated protein kinase. Nature, 1995. 378(6554): p. 307-310.
Müller, G., P. Storz, S. Bourteele, H. Döppler, K. Pfizenmaier, H. Mischak, A. Philipp, C. Kaiser, and W. Kolch, Regulation of Raf‐1 kinase by TNF via its second messenger ceramide and cross‐talk with mitogenic signalling. The EMBO Journal, 1998. 17(3): p. 732-742.
Kempisty, B., K. Zaorska, D. Bukowska, M. Nowak, and S. Ciesiółka, Association between Polymorphic Variants of RAF1 Gene with Occurrence of Mammary Tumor and Aging in Canines. J Drug Discov Develop and Deliv, 2014. 1(2): p. 8.
Wang, H.-G., U.R. Rapp, and J.C. Reed, Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 1996. 87(4): p. 629-638.
Zambon, C.-F., D. Basso, F. Navaglia, C. Belluco, A. Falda, P. Fogar, E. Greco, N. Gallo, M. Rugge, and F. Di Mario, Pro-and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine, 2005. 29(4): p. 141-152.
Chakravorty, M., C.A. Datta De D, A. Santra, and S. Roychoudhury, Association of specific haplotype of TNFalpha with Helicobacter pylori-mediated duodenal ulcer in eastern Indian population. J Genet, 2008. 87(3): p. 299-304.
Sugimoto, M., T. Furuta, N. Shirai, A. Nakamura, F. Xiao, M. Kajimura, H. Sugimura, and A. Hishida, Different effects of polymorphisms of tumor necrosis factor‐alpha and interleukin‐1 beta on development of peptic ulcer and gastric cancer. Journal of gastroenterology and hepatology, 2007. 22(1): p. 51-59.
SeilanianToosi, M., H. Rafatpanah, J. TavakkolAfshar, M. GhavamNassiri, H. Sima, M. MalekzadehMoghani, and R. Ganjali, The Role of Tumor Necrosis Factor-αα| Promoter Polymorphisms in Gastric Carcinoma in Iranians: A Case-Control Study in the North-East of Iran. Govaresh, 2012. 12(3): p. 192-199.
Loh, M., K.X. Koh, B.H. Yeo, C.M. Song, K.S. Chia, F. Zhu, K.G. Yeoh, J. Hill, B. Iacopetta, and R. Soong, Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. European Journal of Cancer, 2009. 45(14): p. 2562-2568.